Literature DB >> 28890588

Informativeness of Diagnostic Marker Values and the Impact of Data Grouping.

Hua Ma1, Andriy I Bandos1, David Gur2.   

Abstract

Assessing performance of diagnostic markers is a necessary step for their use in decision making regarding various conditions of interest in diagnostic medicine and other fields. Globally useful markers could, however, have ranges of values that are "diagnostically non-informative". This paper demonstrates that the presence of marker values from diagnostically non-informative ranges could lead to a loss in statistical efficiency during nonparametric evaluation and shows that grouping non-informative values provides a natural resolution to this problem. These points are theoretically proven and an extensive simulation study is conducted to illustrate the possible benefits of using grouped marker values in a number of practically reasonable scenarios. The results contradict the common conjecture regarding the detrimental effect of grouped marker values during performance assessments. Specifically, contrary to the common assumption that grouped marker values lead to bias, grouping non-informative values does not introduce bias and could substantially reduce sampling variability. The proven concept that grouped marker values could be statistically beneficial without detrimental consequences implies that in practice, tied values do not always require resolution whereas the use of continuous diagnostic results without addressing diagnostically non-informative ranges could be statistically detrimental. Based on these findings, more efficient methods for evaluating diagnostic markers could be developed.

Entities:  

Keywords:  Biomarker evaluation; Diagnostically non-informative values; Grouped marker values; Receiver Operating Characteristic (ROC) analysis; Statistical efficiency

Year:  2017        PMID: 28890588      PMCID: PMC5584883          DOI: 10.1016/j.csda.2017.07.008

Source DB:  PubMed          Journal:  Comput Stat Data Anal        ISSN: 0167-9473            Impact factor:   1.681


  16 in total

1.  Maximum likelihood inference for left-censored HIV RNA data.

Authors:  H S Lynn
Journal:  Stat Med       Date:  2001-01-15       Impact factor: 2.373

2.  Continuous versus categorical data for ROC analysis: some quantitative considerations.

Authors:  R F Wagner; S V Beiden; C E Metz
Journal:  Acad Radiol       Date:  2001-04       Impact factor: 3.173

3.  The analysis of placement values for evaluating discriminatory measures.

Authors:  Margaret Sullivan Pepe; Tianxi Cai
Journal:  Biometrics       Date:  2004-06       Impact factor: 2.571

4.  Ordered multiple-class ROC analysis with continuous measurements.

Authors:  Christos T Nakas; Constantin T Yiannoutsos
Journal:  Stat Med       Date:  2004-11-30       Impact factor: 2.373

5.  Receiver operating characteristic curve inference from a sample with a limit of detection.

Authors:  Neil J Perkins; Enrique F Schisterman; Albert Vexler
Journal:  Am J Epidemiol       Date:  2006-11-16       Impact factor: 4.897

6.  ROC analysis with multiple classes and multiple tests: methodology and its application in microarray studies.

Authors:  Jialiang Li; Jason P Fine
Journal:  Biostatistics       Date:  2008-02-27       Impact factor: 5.899

7.  Radioimmunometric assay for a monoclonal antibody-defined tumor marker, CA 19-9.

Authors:  B C Del Villano; S Brennan; P Brock; C Bucher; V Liu; M McClure; B Rake; S Space; B Westrick; H Schoemaker; V R Zurawski
Journal:  Clin Chem       Date:  1983-03       Impact factor: 8.327

8.  A parametric ROC model-based approach for evaluating the predictiveness of continuous markers in case-control studies.

Authors:  Y Huang; M S Pepe
Journal:  Biometrics       Date:  2009-12       Impact factor: 2.571

9.  On use of partial area under the ROC curve for evaluation of diagnostic performance.

Authors:  Hua Ma; Andriy I Bandos; Howard E Rockette; David Gur
Journal:  Stat Med       Date:  2013-03-18       Impact factor: 2.373

10.  Maximum likelihood ratio tests for comparing the discriminatory ability of biomarkers subject to limit of detection.

Authors:  Albert Vexler; Aiyi Liu; Ekaterina Eliseeva; Enrique F Schisterman
Journal:  Biometrics       Date:  2007-11-19       Impact factor: 1.701

View more
  1 in total

1.  Deep Learning-Based Method of Diagnosing Hyperlipidemia and Providing Diagnostic Markers Automatically.

Authors:  Yuliang Liu; Quan Zhang; Geng Zhao; Guohua Liu; Zhiang Liu
Journal:  Diabetes Metab Syndr Obes       Date:  2020-03-11       Impact factor: 3.168

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.